- President Donald Trump and Vice President Mike Pence had been major supporters of the “right-to-try” legislation, which would bypass drug regulators to give gravely ill patients access to experimental medicines.
- Proponents say this gives patients hope they would not otherwise have.
- Critics say the legislation undermines the FDA’s authority to regulate drugs and could leave patients vulnerable to medicines that might not work or may even be harmful.
American Students and Professors Are Collateral Victims of Zionism
On May 17, Cecilia Culver, a George Washington University double major in economics and statistics and the recipient of GW’s Columbian College of Arts and Sciences (CCAS) Distinguished Scholar Award, came to the stage of GW’s Lisner Auditorium to deliver a...
